| Tavi Knutson, | |
|
227 16th St W Suite 100, Dickinson, ND 58601-5268 | |
| (701) 225-0767 | |
| (701) 225-7123 |
| Full Name | Tavi Knutson |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 227 16th St W Suite 100, Dickinson, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215964267 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 772 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tavi Knutson, 227 16th St W Suite 100, Dickinson, ND 58601-5268 Ph: (701) 225-0767 | Tavi Knutson, 227 16th St W Suite 100, Dickinson, ND 58601-5268 Ph: (701) 225-0767 |
News Archive
It is estimated that one in three women in the United States will have had a hysterectomy by the age of 60. Although the numbers of hysterectomies are decreasing, a new study of more than three thousand women in Michigan who underwent hysterectomy for benign indications reveals that alternatives to hysterectomy are being underused and that treatment guidelines are often not followed.
While physicians are able to treat patients who suffer blood loss after major injuries, a large number of these patients go on to develop infections or multiple organ failure, in which the functioning of the body vital organ systems, such as the lungs, heart, kidneys of liver, go awry.
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
Researchers have found that a protein linked to cell division and migration and tied to increased cell proliferation in ovarian tumors is also present at high levels in breast cancer specimens and cell lines. The protein, dubbed "UNC-45A," was also determined to be more active in breast cancer cells than in normal breast cells.
› Verified 5 days ago
Jaelyn Lowery, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2500 Fairway St, Dickinson, ND 58601 Phone: 701-456-4000 | |
Haylee Peters, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 851 4th Ave E, Dickinson, ND 58601 Phone: 701-456-7247 | |
Kacey Sykora, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 141 3rd St W, Dickinson, ND 58601 Phone: 701-590-9116 Fax: 701-483-4281 | |
Rayel Mccoy, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 683 State Ave, Dickinson, ND 58601 Phone: 701-483-9400 | |
Chelsey P Cox, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 851 4th Ave E, Dickinson, ND 58601 Phone: 701-456-7242 | |
Expression Pediatric Therapy, Pllc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1340 W Villard St Ste A, Dickinson, ND 58601 Phone: 701-590-9116 | |
Adrienne Nancy Belland, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 30 7th St W, Dickinson, ND 58601 Phone: 701-456-4387 Fax: 701-456-4805 |